Press Releases
Landmark UCSF Study Demonstrates Functional Rescue of SCN2A Loss of Function, Underscoring the Potential of Regel Therapeutics' Targeted EpiEditing Platform
September 19, 2025
Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia
September 02, 2025
Venova Medical Receives FDA IDE Approval for the VENOS-3 Pivotal Study of the Velocity™ Percutaneous AVF System
August 22, 2025
Search Technologies
Search to find technologies available for licensing at UCSF Innovation Ventures Database!
Search